Regulation of Th-POK and Runx3 in T cell development in human thymoma

References

• Levine GD, Rosai J. Thymic hyperplasia and neoplasia: A review of current concepts. Hum Pathol. 1978; 9:495–515.
   PubMed Web of Science ®Google Scholar
• Willcox N. Myasthenia gravis. Curr Opin Immunol. 1993; 5:910–917.
   PubMed Web of Science ®Google Scholar
• Levinson AI, Wheatley LM. The thymus and the pathogenesis of myasthenia gravis. Clin Immunol Immunopathol. 1996; 78:1–5.
   PubMedGoogle Scholar
• Palestro G, Geuna M, Novero D, Godio L, Ciccone G, Azzoni L. Immunophenotype of thymoma-associated lymphoid cell component of T-cell type. A new analytic procedure in keeping with structural heterogeneities. Virchows Arch B Cell Pathol. 1990; 59:297–304.
   Google Scholar
• Fujii Y, Hayakawa M, Inada K, Nakahara K. Lymphocytes in thymoma: Association with myasthenia gravis is correlated with increased number of single-positive cells. Eur J Immunol. 1990; 20:2355–2358.
   PubMed Web of Science ®Google Scholar
• Fujii Y, Hayakawa M, Nakahara K. Thymus cells in myasthenia gravis: A two-color flow cytometric analysis of lymphocytes in the thymus and thymoma. J Neurol. 1992; 239:82–88.
   PubMed Web of Science ®Google Scholar
• Inoue M, Okumura M, Fujii Y, Miyoshi S, Shiono H, Fukuhara K, Kadota Y, Matsuda H. Immaturity of lymphocytes in the metastatic lesions of thymoma. Clin Immunol Immunopathol. 1998; 88:249–255.
   PubMedGoogle Scholar
• Inoue M, Fujii Y, Okumura M, Takeuchi Y, Shiono H, Miyoshi S, Matsuda H, Shirakura R. Neoplastic thymic epithelial cells of human thymoma support T cell development from CD4− CD8− cells to CD4+CD8+ cells in vitro. Clin Exp Immunol. 1998; 112:419–426.
   PubMed Web of Science ®Google Scholar
• Takeuchi Y, Fujii Y, Okumura M, Inada K, Nakahara K, Matsuda H. Accumulation of immature CD3− CD4+CD8− single-positive cells that lack CD69 in epithelial cell tumors of the human thymus. Cell Immunol. 1995; 161:181–187.
   PubMed Web of Science ®Google Scholar
• Inoue M, Okumura M, Miyoshi S, Shiono H, Fukuhara K, Kadota Y, Shirakura R, Matsuda H. Impaired expression of MHC class II molecules in response to interferon-gamma (IFN-γ) on human thymoma neoplastic epithelial cells. Clin Exp Immunol. 1999; 117:1–7.
   PubMed Web of Science ®Google Scholar
• He X, He X, Dave VP, Zhang Y, Hua X, Nicolas E, Xu W, Roe BA, Kappes DJ. The zinc finger transcription factor Th-POK regulates CD4 versus CD8 T-cell lineage commitment. Nature. 2005; 433:826–833.
   PubMed Web of Science ®Google Scholar
• Sun G, Liu X, Mercado P, Jenkinson SR, Kypriotou M, Feigenbaum L, Galéra P, Bosselut R. The zinc finger protein cKrox directs CD4 lineage differentiation during intrathymic T cell positive selection. Nat Immunol. 2005; 6:373–381.
   PubMed Web of Science ®Google Scholar
• Setoguchi R, Tachibana M, Naoe Y, Muroi S, Akiyama K, Tezuka C, Okuda T, Taniuchi I. Repression of the transcription factor Th-POK by Runx complexes in cytotoxic T cell development. Science. 2008; 319:822–825.
   PubMed Web of Science ®Google Scholar
• Wildt KF, Sun G, Grueter B, Fischer M, Zamisch M, Ehlers M, Bosselut R. The transcription factor Zbtb7b promotes CD4 expression by antagonizing Runx-mediated activation of the CD4 silencer. J Immunol. 2007; 179:4405–4414.
   PubMed Web of Science ®Google Scholar
• Muroi S, Naoe Y, Miyamoto C, Akiyama K, Ikawa T, Masuda K, Kawamoto H, Taniuchi I. Cascading suppression of transcriptional silencers by ThPOK seals helper T cell fate. Nat Immunol. 2008; 9:1113–1121.
   PubMed Web of Science ®Google Scholar
• Egawa T, Littman DR. ThPOK acts late in specification of the helper T cell lineage and suppresses Runx-mediated commitment to the cytotoxic T cell lineage. Nat Immunol. 2008; 9:1131–1139.
   PubMed Web of Science ®Google Scholar
• Masaoka A, Monden Y, Nakahara K, Tanioka T. Follow-up study of thymomas with special reference to their clinical stages. Cancer. 1981; 48:2485–2492.
   PubMed Web of Science ®Google Scholar
• World Health Organization Classification of Tumors. Pathology and genetics of tumors of the lung, pleura, thymus and heart. Lyon: International Agency for Research on Cancer (IARC) Press.2004.
   Google Scholar
• Okumura M, Fujii Y, Miyoshi S, Shiono H, Inoue M, Kadota Y, Fukuhara K, Matsuda H. Three-color flow cytometric study on lymphocytes derived from thymic diseases. J Surg Res. 2001; 101:130–137.
   PubMed Web of Science ®Google Scholar
• Inoue M, Fujii Y, Okumura M, Takeuchi Y, Shiono H, Miyoshi S, Matsuda H, Shirakura R. Mature CD4 single positive thymocytes in human Thymoma: T cell may differentiate in the thymic epithelial cell tumor. Pathobiology. 1997; 65:216–222.
   PubMed Web of Science ®Google Scholar
• Kadota Y, Okumura M, Miyoshi S, Kitagawa-Sakakida S, Inoue M, Shiono H, Maeda Y, Kinoshita T, Shirakura R, Matsuda H. Altered T cell development in human thymoma is related to impairment of MHC class II transactivator expression induced by interferon-gamma (IFN-γ). Clin Exp Immunol. 2000; 121:59–68.
   PubMed Web of Science ®Google Scholar
• Wang L, Wildt KF, Zhu J, Zhang X, Feigenbaum L, Tessarollo L, Paul WE, Fowlkes BJ, Bosselut R. Distinct functions for the transcription factors GATA-3 and Th-POK during intrathmic differentiation of CD4+ T cells. Nat Immunol. 2008; 10:1122–1130.
   Google Scholar
• Nawijin MC, Ferreira R, Dingjan GM, Kahre O, Drabek D, Karis A, Grosveld F, Hendriks RW. Enforced expression of GATA-3 during T cell development inhibits maturation of CD8 single-positive cells and induces thymic lymphoma in transgenic mice. J Immunol. 2001; 167:714–723.
   Web of Science ®Google Scholar
• Hernández-Hoyos G, Anderson MK, Wang C, Rothenberg EV, Alberola-Ila J. GATA-3 expression is controlled by TCR signals and regulates CD4/CD8 differentiation. Immunity. 2003; 19:83–94.
   PubMed Web of Science ®Google Scholar
• Pai SY, Truitt ML, Ting CN, Leiden JM, Glimcher LH, Ho IC. Critical roles for transcription factor GATA-3 in thymocyte development. Immunity. 2003; 19:863–875.
   PubMed Web of Science ®Google Scholar
• Woolf E, Xiao C, Fainaru O, Lotem J, Rosen D, Negreanu V, Bernstein Y, Goldenberg D, Brenner O, Berke G, . Runx3 and Runx1 are required for CD8 T cell development during thymopoiesis. Proc Natl Acad Sci USA. 2003; 100:7731–7736.
   PubMed Web of Science ®Google Scholar
• Taniuchi I, Osato M, Egawa T, Sunshine MJ, Bae SC, Komori T, Ito Y, Littman DR. Differential requirements for Runx protein in CD4 repression and epigenetic silencing during T lymphocyte development. Cell. 2002; 111:621–633.
   PubMed Web of Science ®Google Scholar
• Inada K, Okumura M, Shiono H, Inoue M, Kadota Y, Ohta M, Matsuda H. Role of positive of thymoma-associated T cells in the pathogenesis of myasthenia gravis. J Surg Res. 2005; 126:34–40.
   PubMed Web of Science ®Google Scholar
• Okumura M, Fujii Y, Shiono H, Inoue M, Minami M, Utsumi T, Kadota Y, Sawa Y. Immunological function of thymoma and pathogenesis of pareneoplastic myasthenia gravis. Gen Thorac Cardiovasc Surg. 2008; 56:143–150.
   PubMedGoogle Scholar
• Ströbel P, Chuang WY, Chuvpilo S, Zettl A, Katzenberger T, Kalbacher H, Riekmann P, Nix W, Schalke B, Gold R, . Commom cellular and diverse genetic basis of thymoma-associated myasthenia gravis: Role of MHC class II and AIRE genes and genetic polymorphisms. Ann N Y Acad Sci. 2008; 1132:143–156.
   PubMed Web of Science ®Google Scholar
• Nakajima J, Murakawa T, Fukami T, Sano A, Takamoto S, Ohtsu H. Postthymectomy myasthenia gravis: Relationship with thymoma and antiacetyllcholine receptor antibody. Ann Thorac Surg. 2008; 86:941–945.
   PubMed Web of Science ®Google Scholar
• Buckley C, Douek D, Newsom-Davis J, Vincent A, Willcox N. Mature, long-lived CD4+ and CD8+ T cells are generated by the thymoma in myasthenia gravis. Ann Neurol. 2001; 50:64–72.
   PubMed Web of Science ®Google Scholar
• Hoffacker V, Schultz A, Tiesinga JJ, Gold R, Schalke B, Nix W, Kiefer R, Müller-Hermelink HK, Marx A. Thymomas alter the T-cell subset composition in the blood: A potential mechanism for thymoma-associated autoimmune disease. Blood. 2000; 96:3872–3879.
   PubMed Web of Science ®Google Scholar
• Ströbel P, Helmreich M, Menioudakis G, Lewin SR, Rüdiger T, Bauer A, Hoffacker V, Gold R, Nix W, Schalke B, . Paraneoplastic myasthenia gravis correlates with generation of mature naïve CD4+ T cells in thymomas. Blood. 2002; 100:159–166.
   PubMed Web of Science ®Google Scholar
• De Rosa SC, Herzenberg LA, Herzenberg LA, Roederer M. 11-Color, 13-parameter flow cytometry: Identification of human naïve T cells by phenotype, function, and T-cell receptor diversity. Nat Med. 2001; 7:245–248.
   PubMed Web of Science ®Google Scholar
• Okumura M, Fujii Y, Inada K, Nakahara K, Matsuda H. Both CD45RA+ and CD45RA− subpopulations of CD8+ T cells contain cells with high levels of lymphocytes function-associated antigen-1 expression, a phenotype of primed T cells. J Immunol. 1993; 150:429–437.
   PubMed Web of Science ®Google Scholar
• Fukui Y, Ishimoto T, Utsuyama M, Gyotoku T, Koga T, Nakao K, Hirokawa K, Katsuki M, Sasazuki T. Positive and negative CD4+ thymocyte selection by a single MHC class II/peptide ligand affected by its expression level in the thymus. Immunity. 1997; 6:401–410.
   PubMed Web of Science ®Google Scholar
• Hogquist KA, Jameson SC, Heath WR, Howard JL, Bevan MJ, Carbone FR. T cell receptor antagonist peptide induce positive selection. Cell. 1994; 76:17–27.
   PubMed Web of Science ®Google Scholar